Invicta Diagnostic Secures NSE Emerge Approval for ₹28 Crore IPO
Invicta Diagnostic Ltd, operator of PC Diagnostics brand, has received in-principle approval from NSE Emerge for its ₹28 crore IPO. The company plans to issue 33,08,800 fresh equity shares with a face value of ₹10 each. ₹21.11 crore from the proceeds will be used to establish five new diagnostic centres in Maharashtra. Invicta has shown significant growth, expanding from one to seven centres, with revenue increasing by 90% to ₹30.09 crore and profit after tax rising to ₹4.92 crore. The company offers a wide range of pathology and radiology tests.
*this image is generated using AI for illustrative purposes only.
Invicta Diagnostic Ltd, the operator of PC Diagnostics brand diagnostic centres, has received in-principle approval from NSE Emerge for its Initial Public Offering (IPO). The company, which filed its Draft Red Herring Prospectus (DRHP) in July, is set to raise ₹28 crore through the fresh issuance of 33,08,800 equity shares with a face value of ₹10 each via the book-building route.
IPO Details
- Issue Size: ₹28 crore
- Fresh Issuance: 33,08,800 equity shares
- Face Value: ₹10 per share
- Book Running Lead Manager: Socradamus Capital Private Ltd
- Registrar: Bigshare Services Private Ltd
Utilization of IPO Proceeds
Invicta Diagnostic plans to allocate ₹21.11 crore from the IPO proceeds towards capital expenditure for establishing five new diagnostic centres in Maharashtra. The new centres will be located in:
- Kalyan
- Vasai-Virar
- Malad-Kandivali
- Akola
The company intends to follow a hub-and-spoke model for its expansion.
Company Growth and Performance
Invicta Diagnostic has shown significant growth over the past few years:
- Expanded from one centre to seven centres
- Operates from a flagship hub in Thane
Performance Highlights
| Metric | Value |
|---|---|
| Pathology Tests Conducted | 79,727 |
| Radiology Tests Conducted | 96,521 |
| Total Patients Served | 1,03,602 |
| Revenue from Operations | ₹30.09 crore |
| Profit After Tax | ₹4.92 crore |
The revenue from operations showed a 90% growth from ₹15.83 crore in the previous year, while the Profit After Tax increased from ₹3.80 crore.
Service Offerings
Invicta Diagnostic provides a comprehensive range of diagnostic services:
- Pathology Tests:
- 60 routine tests
- 487 specialised tests
- Radiology Tests:
- 96 basic tests
- 130 advanced tests
The company's expansion plans and robust financial performance indicate its strong position in the diagnostic services sector. With the upcoming IPO, Invicta Diagnostic aims to capitalize on its growth trajectory and further strengthen its presence in Maharashtra's diagnostic market.
18
